Lifecore Biomedical, Inc. provided revenue guidance for full year fiscal 2024. For the period, the company expects revenue to be in the range of $125 million to $130 million, depending on timing of customer shipments in fiscal fourth quarter.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.455 USD | -2.12% | +2.86% | +4.52% |
Apr. 19 | Lifecore Biomedical Gets Nasdaq Warning Over Delayed Quarterly Report | MT |
Apr. 01 | Lifecore Biomedical, Inc. Provides Revenue Guidance for Full Year Fiscal 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.17% | 201M | |
+25.83% | 661B | |
+26.74% | 566B | |
-6.62% | 352B | |
+19.50% | 332B | |
+3.45% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.58% | 145B |
- Stock Market
- Equities
- LFCR Stock
- News Lifecore Biomedical, Inc.
- Lifecore Biomedical, Inc. Provides Revenue Guidance for Full Year Fiscal 2024